United States:
President Signs Drug Quality And Security Act
04 December 2013
Fox Rothschild LLP
To print this article, all you need is to be registered or login on Mondaq.com.
On November 27, 2013, President Obama signed the Drug Quality and Security Act, which amends
the Food, Drug, and Cosmetic Act. The bill
was originally introduced in the House of Representatives (as H.R.
3204) and significantly alters the regulation of compounded
drugs.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
